Cargando…

Predictors of early death in female patients with breast cancer in the UK: a cohort study

OBJECTIVE: To identify factors predicting early death in women with breast cancer. DESIGN: Cohort study. SETTING: 29 trusts across seven cancer networks in the North Thames area. PARTICIPANTS: 15 037 women with primary breast cancer diagnosed between January 1996 and December 2005. METHODS: Logistic...

Descripción completa

Detalles Bibliográficos
Autores principales: Stapelkamp, Ceilidh, Holmberg, Lars, Tataru, Daniela, Møller, Henrik, Robinson, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227804/
https://www.ncbi.nlm.nih.gov/pubmed/22123920
http://dx.doi.org/10.1136/bmjopen-2011-000247
_version_ 1782217786494287872
author Stapelkamp, Ceilidh
Holmberg, Lars
Tataru, Daniela
Møller, Henrik
Robinson, David
author_facet Stapelkamp, Ceilidh
Holmberg, Lars
Tataru, Daniela
Møller, Henrik
Robinson, David
author_sort Stapelkamp, Ceilidh
collection PubMed
description OBJECTIVE: To identify factors predicting early death in women with breast cancer. DESIGN: Cohort study. SETTING: 29 trusts across seven cancer networks in the North Thames area. PARTICIPANTS: 15 037 women with primary breast cancer diagnosed between January 1996 and December 2005. METHODS: Logistic regression analyses to determine predictors of early death and factors associated with lack of surgical treatment. MAIN EXPOSURES: Age at diagnosis, mode of presentation, ethnicity, disease severity, comorbidities, treatment and period of diagnosis in relation to the Cancer Plan (the NHS's strategy in 2000 for investment in and reform of cancer services). MAIN OUTCOME MEASURES: Death from any cause within 1 year of diagnosis, and receipt of surgical treatment. RESULTS: By 31 December 2006, 4765 women had died, 980 in the year after diagnosis. Older age and disease severity independently predicted early death. Women over 80 were more likely to die early than women under 50 (OR 8.05, 95% CI 5.96 to 10.88). Presence of distant metastases on diagnosis increased the odds of early death more than eightfold (OR 8.41, 95% CI 6.49 to 10.89). Two or more recorded comorbidities were associated with a nearly fourfold increase. There was a significant decrease in odds associated with surgery (OR 0.29, 95% CI 0.24 to 0.35). Independently of disease severity and comorbidities, women over 70 were less likely than those under 50 to be treated surgically and this was even more pronounced in those aged over 80 (OR 0.09, 95% CI 0.07 to 0.10). Other factors independently associated with a reduced likelihood of surgery included a non-screening presentation, non-white ethnicity and additional comorbidities. CONCLUSIONS: These findings may partially explain the survival discrepancies between the UK and other European countries in female patients with breast cancer. The study identifies a group of women with a particularly poor prognosis for whom interventions aiming at early detection may be targeted.
format Online
Article
Text
id pubmed-3227804
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-32278042011-12-01 Predictors of early death in female patients with breast cancer in the UK: a cohort study Stapelkamp, Ceilidh Holmberg, Lars Tataru, Daniela Møller, Henrik Robinson, David BMJ Open Oncology OBJECTIVE: To identify factors predicting early death in women with breast cancer. DESIGN: Cohort study. SETTING: 29 trusts across seven cancer networks in the North Thames area. PARTICIPANTS: 15 037 women with primary breast cancer diagnosed between January 1996 and December 2005. METHODS: Logistic regression analyses to determine predictors of early death and factors associated with lack of surgical treatment. MAIN EXPOSURES: Age at diagnosis, mode of presentation, ethnicity, disease severity, comorbidities, treatment and period of diagnosis in relation to the Cancer Plan (the NHS's strategy in 2000 for investment in and reform of cancer services). MAIN OUTCOME MEASURES: Death from any cause within 1 year of diagnosis, and receipt of surgical treatment. RESULTS: By 31 December 2006, 4765 women had died, 980 in the year after diagnosis. Older age and disease severity independently predicted early death. Women over 80 were more likely to die early than women under 50 (OR 8.05, 95% CI 5.96 to 10.88). Presence of distant metastases on diagnosis increased the odds of early death more than eightfold (OR 8.41, 95% CI 6.49 to 10.89). Two or more recorded comorbidities were associated with a nearly fourfold increase. There was a significant decrease in odds associated with surgery (OR 0.29, 95% CI 0.24 to 0.35). Independently of disease severity and comorbidities, women over 70 were less likely than those under 50 to be treated surgically and this was even more pronounced in those aged over 80 (OR 0.09, 95% CI 0.07 to 0.10). Other factors independently associated with a reduced likelihood of surgery included a non-screening presentation, non-white ethnicity and additional comorbidities. CONCLUSIONS: These findings may partially explain the survival discrepancies between the UK and other European countries in female patients with breast cancer. The study identifies a group of women with a particularly poor prognosis for whom interventions aiming at early detection may be targeted. BMJ Group 2011-11-28 /pmc/articles/PMC3227804/ /pubmed/22123920 http://dx.doi.org/10.1136/bmjopen-2011-000247 Text en © 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Oncology
Stapelkamp, Ceilidh
Holmberg, Lars
Tataru, Daniela
Møller, Henrik
Robinson, David
Predictors of early death in female patients with breast cancer in the UK: a cohort study
title Predictors of early death in female patients with breast cancer in the UK: a cohort study
title_full Predictors of early death in female patients with breast cancer in the UK: a cohort study
title_fullStr Predictors of early death in female patients with breast cancer in the UK: a cohort study
title_full_unstemmed Predictors of early death in female patients with breast cancer in the UK: a cohort study
title_short Predictors of early death in female patients with breast cancer in the UK: a cohort study
title_sort predictors of early death in female patients with breast cancer in the uk: a cohort study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227804/
https://www.ncbi.nlm.nih.gov/pubmed/22123920
http://dx.doi.org/10.1136/bmjopen-2011-000247
work_keys_str_mv AT stapelkampceilidh predictorsofearlydeathinfemalepatientswithbreastcancerintheukacohortstudy
AT holmberglars predictorsofearlydeathinfemalepatientswithbreastcancerintheukacohortstudy
AT tatarudaniela predictorsofearlydeathinfemalepatientswithbreastcancerintheukacohortstudy
AT møllerhenrik predictorsofearlydeathinfemalepatientswithbreastcancerintheukacohortstudy
AT robinsondavid predictorsofearlydeathinfemalepatientswithbreastcancerintheukacohortstudy